G Gatta

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. ncbi request reprint Childhood cancer survival in Europe and the United States
    Gemma Gatta
    Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer 95:1767-72. 2002
  2. ncbi request reprint Cancer survival in European adolescents and young adults
    G Gatta
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Eur J Cancer 39:2600-10. 2003
  3. ncbi request reprint Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology
    G Gatta
    Istituto Nazionale per lo Studio e la Cura dei Tumori, Division of Epidemiology, Via Venezian 1, 1 20133 Milan, Italy
    Eur J Cancer 39:2214-22. 2003
  4. ncbi request reprint Colon cancer prevalence and estimation of differing care needs of colon cancer patients
    G Gatta
    Istituto Nazionale per lo Studio e la Cura dei Tumori, Epidemiology Unit, Milan
    Ann Oncol 15:1136-42. 2004
  5. pmc Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study
    G Gatta
    Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Gut 47:533-8. 2000
  6. doi request reprint Survival of European children and young adults with cancer diagnosed 1995-2002
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
    Eur J Cancer 45:992-1005. 2009
  7. ncbi request reprint Childhood cancer survival in Europe
    G Gatta
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Ann Oncol 14:v119-27. 2003
  8. ncbi request reprint Childhood cancer survival trends in Europe: a EUROCARE Working Group study
    Gemma Gatta
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milano, Italy
    J Clin Oncol 23:3742-51. 2005
  9. ncbi request reprint Cancer survival increases in Europe, but international differences remain wide
    M Sant
    Department of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan, Italy
    Eur J Cancer 37:1659-67. 2001
  10. pmc Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery
    L Ciccolallo
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian, 1, 20133 Milan, Italy
    Gut 54:268-73. 2005

Detail Information

Publications62

  1. ncbi request reprint Childhood cancer survival in Europe and the United States
    Gemma Gatta
    Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer 95:1767-72. 2002
    ..The objective of this study was to determine whether transatlantic differences in survival also are present in childhood cancers...
  2. ncbi request reprint Cancer survival in European adolescents and young adults
    G Gatta
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Eur J Cancer 39:2600-10. 2003
    ....
  3. ncbi request reprint Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology
    G Gatta
    Istituto Nazionale per lo Studio e la Cura dei Tumori, Division of Epidemiology, Via Venezian 1, 1 20133 Milan, Italy
    Eur J Cancer 39:2214-22. 2003
    ..The main explanatory difference is the proportion of adenocarcinoma in polyps...
  4. ncbi request reprint Colon cancer prevalence and estimation of differing care needs of colon cancer patients
    G Gatta
    Istituto Nazionale per lo Studio e la Cura dei Tumori, Epidemiology Unit, Milan
    Ann Oncol 15:1136-42. 2004
    ..We estimated the proportions of the prevalent colon cancer cases requiring initial care, terminal care and follow-up...
  5. pmc Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study
    G Gatta
    Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Gut 47:533-8. 2000
    ..Marked differences in population based survival across Europe were found for colorectal cancers diagnosed in 1985-1989...
  6. doi request reprint Survival of European children and young adults with cancer diagnosed 1995-2002
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
    Eur J Cancer 45:992-1005. 2009
    ..Cancer survival in patients <25 years is poorly documented in Eastern European countries. Complete cancer registration should be a priority for these countries as an essential part of a policy for effective cancer control in Europe...
  7. ncbi request reprint Childhood cancer survival in Europe
    G Gatta
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Ann Oncol 14:v119-27. 2003
    ..EUROCARE-3 collected data from 45 population-based cancer registries in 20 countries on 24 620 European children aged from 0 to 14 years diagnosed with malignancy in the period 1990-1994...
  8. ncbi request reprint Childhood cancer survival trends in Europe: a EUROCARE Working Group study
    Gemma Gatta
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milano, Italy
    J Clin Oncol 23:3742-51. 2005
    ..EUROCARE collected data from population-based cancer registries in 20 European countries. We used this data to compare childhood cancer survival time trends in Europe...
  9. ncbi request reprint Cancer survival increases in Europe, but international differences remain wide
    M Sant
    Department of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan, Italy
    Eur J Cancer 37:1659-67. 2001
    ..The persisting regional differences suggest there are corresponding differences in the availability of diagnostic and therapeutic facilities, and in the effectiveness of healthcare systems...
  10. pmc Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery
    L Ciccolallo
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian, 1, 20133 Milan, Italy
    Gut 54:268-73. 2005
    ..Population based colorectal cancer survival among patients diagnosed in 1985-89 was lower in Europe than in the USA (45% v 59% five year relative survival)...
  11. doi request reprint The advantage of women in cancer survival: an analysis of EUROCARE-4 data
    A Micheli
    Descriptive Epidemiology and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Cancer 45:1017-27. 2009
    ....
  12. ncbi request reprint Estimated incidence and prevalence of female breast cancer in Italian regions
    A Micheli
    Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Tumori 78:13-21. 1992
    ..In 1987, about 250,000 Italian women had a present or past history of breast cancer: for the 1970-1987 period, prevalence has increased by approximately 5,500 cases per year...
  13. ncbi request reprint Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group
    M Sant
    Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Int J Cancer 77:679-83. 1998
    ..Low survival in the United Kingdom may be due to inadequate adherence to consensus treatment guidelines and greater variation in treatment...
  14. ncbi request reprint Breast cancer prevalence measured by the Lombardy Cancer Registry
    A Micheli
    Division of Epidemiology, National Cancer Institute, Milan, Italy
    Tumori 83:875-9. 1997
    ..CONCLUSION: Owing to aging of the population, the improvement in survival and the increasing incidence, the number of prevalent cases will increase. This phenomenon has and will have great importance for the health planning...
  15. doi request reprint The burden of rare cancers in Europe
    Gemma Gatta
    Fondazione IRCCS Istituto Nazionale dei Tumori, Dipartimento di Medicina Predittiva e per la Prevenzione, Unità di Epidemiologia Valutativa, Via Venezian, 1, 20133, Milan, Italy
    Adv Exp Med Biol 686:285-303. 2010
    ..The burden indicators were estimated and are provided in this chapter...
  16. doi request reprint Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study
    G Zigon
    Evaluative Epidemiology, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Ann Oncol 22:165-74. 2011
    ..The aim of this study was to analyse survival for European head and neck cancer patients in populations covered by population-based cancer registries (CRs), in relation to tumour subsite as prognostic factor...
  17. ncbi request reprint Cancer prevalence in European registry areas
    A Micheli
    Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
    Ann Oncol 13:840-65. 2002
    ..Information on cancer prevalence is of major importance for health planning and resource allocation. However, systematic information on cancer prevalence is largely unavailable...
  18. ncbi request reprint Studying survival of cancer patients in different populations: its potential and role
    A Micheli
    Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Tumori 83:3-8. 1997
    ..Being the outcome of a number of individual, social and economical aspects, population-based survival may be thought as index for measuring the level of a country's development...
  19. doi request reprint EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary
    Milena Sant
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Cancer 45:931-91. 2009
    ..For all cancers, 5-year survival conditional to surviving 1-year was higher and varied less with region, than the overall relative survival...
  20. ncbi request reprint EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary
    M Sant
    Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Ann Oncol 14:v61-118. 2003
    ..The affluence of countries influenced overall cancer survival through the availability of adequate diagnostic and treatment procedures, and screening programmes...
  21. ncbi request reprint The ITACARE Study
    M Sant
    Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Tumori 83:17-24. 1997
    ..Overall mortality decreased during the period, more markedly in the north and among women...
  22. ncbi request reprint Variations in the survival of adult cancer patients in Italy
    G Gatta
    Istituto Nazionale per la Cura e lo Studio dei Tumori, Milan, Italy
    Tumori 83:497-504. 1997
    ..The unfavorable trend with increasing age may be due to increasing difficulty in applying complete therapy protocols as general health declines, sometimes in relation to an advanced cancer stage at diagnosis...
  23. ncbi request reprint Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study
    G Gatta
    Istituto Nazionale per lo Studio e la Cura e dei Tumori, Divisione di Epidemiologia, Via Venezian, 1, 20133 Milan, Italy
    Eur J Cancer 37:695-702. 2001
    ..Since these rare childhood malignancies were virtually untreatable until 1970, these are very welcome trends...
  24. doi request reprint Survival from salivary glands adenoid cystic carcinoma in European populations
    Laura Ciccolallo
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Oral Oncol 45:669-74. 2009
    ..Improvements in the disease detection in its early stage and international collaborative research should be encouraged...
  25. ncbi request reprint Life tables for world-wide comparison of relative survival for cancer (CONCORD study)
    Paolo Baili
    Descriptive Epidemiology and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Tumori 94:658-68. 2008
    ....
  26. ncbi request reprint Incident lung cancer survival. Long-term follow-up of a population-based study in Italy
    U Pastorino
    Department of Thoracic Surgery (OCT, National Cancer Institute, Milan, Italy
    Tumori 76:199-204. 1990
    ....
  27. ncbi request reprint The prevalence of colorectal cancer in Italy
    G Gatta
    Epidemiology Division, National Cancer Institute, Milan, Italy
    Tumori 85:387-90. 1999
    ..CONCLUSIONS: 70% of the prevalent patients diagnosed within 5 years prior to the prevalence date were likely to require care for cancer recurrence, while 13% of the prevalent cases required care for distant metastases...
  28. ncbi request reprint Randomized trial of primary school education against smoking
    G Gatta
    Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Tumori 77:367-71. 1991
    ..72% (p = 0.23) respectively for the intervention and control groups. It was concluded that sporadic educational intervention carried out during primary school years has little or no impact in preventing cigarette smoking in teenagers...
  29. ncbi request reprint The effect of cytological screening on cervical neoplasia in the Italian province of Varese
    G Gatta
    Divisione di Epidemiologia dell'Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
    Tumori 78:295-9. 1992
    ..Actually by 1976, when the Lombardy Cander Registry began its activity, the screening was diffuse throughout the province. These observations are consistent with the preventive effect of screening activity...
  30. doi request reprint Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States
    Milena Sant
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I 20133, Milan, Italy
    Eur J Cancer 44:579-87. 2008
    ..Interpretation of marked variation in survival with morphology is complicated by classification inconsistencies. The completeness and standardisation of cancer registry morphology data needs to be improved...
  31. doi request reprint Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Acta Oncol 49:776-83. 2010
    ....
  32. ncbi request reprint International collaborations in cancer control and the Third International Cancer Control Congress
    Andrea Micheli
    Descriptive Studies and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Tumori 95:579-96. 2009
    ..As a consequence, less resources of development aids are allocated to control NCDs including cancer...
  33. doi request reprint Rectal cancer
    Maria Giulia Zampino
    Medical Care Unit, European Institute of Oncology, Milan, Italy
    Crit Rev Oncol Hematol 70:160-82. 2009
    ..Updated recommendations for the management of these patients are here reported...
  34. doi request reprint Human papillomavirus in HNSCC: a European epidemiologic perspective
    Lisa Licitra
    Head and Neck Medical Oncology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Hematol Oncol Clin North Am 22:1143-53, vii-viii. 2008
    ..Three-year survival rates improved more in human papillomavirus-related than unrelated cancer sites, and women had better rates of survival than men...
  35. doi request reprint Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study
    Gemma Gatta
    Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy
    J Cancer Surviv 1:247-54. 2007
    ....
  36. doi request reprint Survival for ethmoid sinus adenocarcinoma in European populations
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, Milan, Italy
    Acta Oncol 48:992-8. 2009
    ..Adenocarcinoma of the ethmoid sinus is rare. EUROCARE data provide a good opportunity to study the survival of this rare disease in a population of continental size...
  37. doi request reprint Prostate cancer treatment in Europe at the end of 1990s
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy
    Acta Oncol 48:867-73. 2009
    ..We therefore aimed to characterize treatment for prostate cancer across Europe...
  38. ncbi request reprint Cancer of the nasopharynx
    Lisa Licitra
    START Project and Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Crit Rev Oncol Hematol 45:199-213. 2003
    ..Standard therapeutic option for early stages of NPC is radiation, while an integration of radiation therapy and chemotherapy is indicated in more advanced stages...
  39. ncbi request reprint [Case-control evaluation of screening efficacy]
    Franco Berrino
    Unità di epidemiologia eziologica e prevenzione, Dipartimento di medicina preventiva e predittiva, Istituto Nazionale per lo Studio e la Cura dei Tumori di Milano
    Epidemiol Prev 28:354-9. 2004
  40. ncbi request reprint Survival from rare cancer in adults: a population-based study
    Gemma Gatta
    Epidemiology Unit, National Cancer Institute, Milan, Italy
    Lancet Oncol 7:132-40. 2006
    ..We aimed to study the epidemiology of rare cancers in a large population of several countries...
  41. ncbi request reprint Rectal cancer
    Maria Giulia Zampino
    European Institute of Oncology, Milan, Italy
    Crit Rev Oncol Hematol 51:121-43. 2004
    ..Updated recommendations for the management of these patients are here reported...
  42. ncbi request reprint Ependymoma
    Michele Reni
    Medical Oncology Unit, San Raffaele Scientific Institute, Milan, Italy
    Crit Rev Oncol Hematol 63:81-9. 2007
    ..There is no proof that postoperative chemotherapy improves the outcome. At recurrence, platinum-, nitrosourea- or temozolomide-based chemotherapy can be administered, although there is no evidence of efficacy...
  43. doi request reprint Major and minor salivary gland tumors
    Marco Guzzo
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Crit Rev Oncol Hematol 74:134-48. 2010
    ..Metastatic disease may be either treated with radiotherapy or palliative chemotherapy, depending on the site of metastases. For highly selected patients the employment of anti-androgen therapy is indicated...
  44. ncbi request reprint Ovarian cancer
    Nicoletta Colombo
    European Institute of Oncology, Division of Gynecology, Via Ripamonti 435, Milan, Italy
    Crit Rev Oncol Hematol 60:159-79. 2006
    ..Salvage chemotherapy in platinum-refractory patients usually results in low response rates and short survival...
  45. doi request reprint Cancer prevalence estimates in Europe at the beginning of 2000
    G Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Ann Oncol 24:1660-6. 2013
    ..This paper provides prevalence estimates for 16 major cancers in Europe at the beginning of the year 2003...
  46. ncbi request reprint Adenocarcinoma of ethmoid sinus: an occupational disease
    G Bimbi
    Head and Neck Surgery Department, National Cancer Institute, Milan, Italy
    Acta Otorhinolaryngol Ital 24:199-203. 2004
    ..No significant correlation was observed between exposure and either non-ethmoidal sinonasal neoplasms or ethmoidal tumours other than adenocarcinomas...
  47. ncbi request reprint Cancer of pancreas
    Filippo De Braud
    START Project and European Institute of Oncology, Milan, Italy
    Crit Rev Oncol Hematol 50:147-55. 2004
    ..Radical surgery is indicated for patients with early stage of disease, mainly stage I and partially II. In all other cases, the aim of treatment is the palliation of different very distressing symptoms related to this neoplasm...
  48. doi request reprint Cancer survival in five continents: a worldwide population-based study (CONCORD)
    Michel P Coleman
    Cancer Research UK Cancer Survival Group, Non communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, UK
    Lancet Oncol 9:730-56. 2008
    ..This is, to our knowledge, the first worldwide analysis of cancer survival, with standard quality-control procedures and identical analytic methods for all datasets...
  49. ncbi request reprint Adult acute myeloid leukaemia
    Matthew Smith
    St Bartholomew s Hospital, London, UK
    Crit Rev Oncol Hematol 50:197-222. 2004
    ....
  50. ncbi request reprint Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data
    Arduino Verdecchia
    National Centre for Epidemiology, Health Surveillance and Promotion, Istituto Superiore di Sanita, Rome, Italy
    Lancet Oncol 8:784-96. 2007
    ..We also compared our findings with data on cancer survival in the USA from the US SEER (Surveillance, Epidemiology, and End Results) programme...
  51. ncbi request reprint Regional estimates of prostate cancer burden in Italy
    Riccardo Inghelmann
    Reparto di Epidemiologia dei Tumori, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanita, Rome, Italy
    Tumori 93:380-6. 2007
    ....
  52. ncbi request reprint Incidence of uveal melanoma in Europe
    Gianni Virgili
    Department of Ophthalmology, University of Florence, Florence, Italy
    Ophthalmology 114:2309-15. 2007
    ..To estimate incidence rates of uveal melanoma in Europe from 1983 to 1994...
  53. ncbi request reprint Incidence of and survival from Wilms' tumour in adults in Europe: data from the EUROCARE study
    Emmanuel Mitry
    Service d Hépatogastroentérologie et Oncologie Digestive, Centre Hospitalo Universitaire Ambroise Paré, AP HP, Faculté de Médecine Paris Ile de France Ouest et Université Versailles Saint Quentin, 92100 Boulogne, France
    Eur J Cancer 42:2363-8. 2006
    ..This may, at least partly, be explained by the rarity of this diagnosis. Prognosis may be improved by the use of specific treatment guidelines for nephroblastoma in adults...
  54. doi request reprint Survival in patients with uveal melanoma in Europe
    Gianni Virgili
    Department of Oto Neuro Ophthalmological Surgical Sciences, University of Florence, Viale Morgagni 85, Florence 50134, Italy
    Arch Ophthalmol 126:1413-8. 2008
    ..To estimate survival in patients in whom uveal melanoma was diagnosed between January 1, 1983, and December 31, 1994, in Europe...
  55. ncbi request reprint Explaining gastric cancer survival differences among European countries
    Arduino Verdecchia
    Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanita, Viale Regina Elena 299, 00161 Rome, Italy
    Int J Cancer 109:737-41. 2004
    ..There is a need to improve completeness and standardization of detailed information collected on gastric cancer patients to allow detailed comparative analyses and interpretation...
  56. ncbi request reprint Adult acute lymphoblastic leukaemia
    Renato Bassan
    Ospedali Riuniti, Bergamo, Italy
    Crit Rev Oncol Hematol 50:223-61. 2004
    ..Therapeutic progress may be obtainable through a careful integration of chemotherapy, stem cell transplantation, and the new targeted treatments with highly specific metabolic inhibitors and humanised monoclonal antibodies...
  57. ncbi request reprint Cancer of the prostate
    Sergio Bracarda
    Ospedale Silvestrini, Azienda Ospedaliera di Perugia, Italy
    Crit Rev Oncol Hematol 56:379-96. 2005
    ..5 months) and quality of life with docetaxel in more than 1,600 cases...
  58. ncbi request reprint Renal cancer
    Enrichetta Corgna
    Ospedale Silvestrini, Azienda Ospedaliera di Perugia, Italy
    Crit Rev Oncol Hematol 64:247-62. 2007
    ..Biologic agents represent the major effective therapies for widespread metastatic renal cancer. An antiangiogenic strategy, the neutralization of VEGF, can slow the growth rate of advanced cancer...
  59. ncbi request reprint Colon cancer
    Roberto Labianca
    Ospedali Riuniti, Bergamo, Italy
    Crit Rev Oncol Hematol 51:145-70. 2004
    ..This report summarizes the most important achievements in this field and provides the readers useful suggestions for their professional practice...
  60. ncbi request reprint Anaplastic astrocytoma in adults
    Roger Stupp
    University Hospital CHUV, Lausanne, Switzerland
    Crit Rev Oncol Hematol 63:72-80. 2007
    ..In recurrent disease, chemotherapy with temozolomide has been proven to be active and well-tolerated in phase II trials, but no comparative phase III trials of other cytotoxic drugs have been conducted...
  61. doi request reprint Glioblastoma in adults
    Alba A Brandes
    Department of Medical Oncology, Bellaria Maggiore Hospital, Azienda ASL, Bologna, Italy
    Crit Rev Oncol Hematol 67:139-52. 2008
    ..At time of recurrence/progression, a nitrosourea-based chemotherapy constitutes a reasonable option, as well as a temozolomide re-challenge for patients without progression during prior temozolomide treatment...
  62. doi request reprint Oligodendroglioma
    Martin J van den Bent
    Daniel den Hoed Cancer Clinic Erasmus University Medical Center, Rotterdam, The Netherlands
    Crit Rev Oncol Hematol 66:262-72. 2008
    ..Adjuvant PCV chemotherapy increased progression-free survival but does not improve survival as compared to PCV given at recurrence. Chemotherapy with either PCV or temozolomide constitutes a standard for recurrent/progressive disease...